Compare $PBYI vs $PROK | Chartloom

Compare

$PBYI vs $PROK

Puma Biotechnology Inc · Prokidney Corp

PBYI

Puma Biotechnology Inc

PROK

Prokidney Corp

Compare $PBYI vs $PROK

Comparing Puma Biotechnology Inc and Prokidney Corp

PBYIPuma Biotechnology Inc

PROKProkidney Corp

PBYIPuma Biotechnology Inc

Market cap

$524M

P/E (TTM)

20.26x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-2.9%

YTD performance

78.3%

52W performance

96.7%

FCF yield

7.8%

PROKProkidney Corp

Market cap

$526M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

788.85x

Rev growth (TTM)

55.2%

YTD performance

-22.0%

52W performance

-46.6%

FCF yield

-30.4%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

PBYI

PROK

Detailed metrics comparison

PBYI

Puma Biotechnology Inc

PROK

Prokidney Corp

Market Cap

PBYI$524M

PROK$526M

Enterprise Value

PBYI$487M

PROK$451M

Price

PBYI$10.29

PROK$1.74

P/E Ratio

PBYI20.26x

PROKN/A

P/S Ratio

PBYI2.26x

PROK642.52x

EV/Sales

PBYI2.11x

PROK551.08x

EV/EBITDA

PBYI10.51x

PROK0.00x

P/B Ratio

PBYI3.54x

PROK78.79x

P/FCF Ratio

PBYI12.75x

PROKN/A

EV/FCF

PBYI11.86x

PROK-2.82x

PEG Ratio

PBYIN/A

PROKN/A

Forward P/E (NTM)

PBYIN/A

PROKN/A

Forward P/S (NTM)

PBYIN/A

PROK788.85x

Revenue (TTM)

PBYI$231M

PROK$818K

Revenue Growth (YoY)

PBYI-2.9%

PROK55.2%

Forward Rev Growth

PBYI-1.4%

PROK-44.4%

Gross Margin (TTM)

PBYI74.8%

PROK0.0%

Operating Margin (TTM)

PBYI13.2%

PROK0.0%

EBITDA Margin (TTM)

PBYI17.7%

PROK-20827.6%

Net Margin (TTM)

PBYI11.6%

PROK-10288.4%

FCF Margin (TTM)

PBYI17.8%

PROK-19527.4%

Net Income (TTM)

PBYI$27M

PROK$-84M

FCF (TTM)

PBYI$41M

PROK$-160M

EPS (TTM)

PBYI$0.51

PROK-$0.45

ROE (TTM)

PBYI20.8%

PROK-2810.2%

ROA (TTM)

PBYI13.3%

PROK-2739.0%

ROIC (TTM)

PBYI18.4%

PROK0.0%

Cash

PBYI$37M

PROK$75M

Debt

PBYI$0

PROK$67K

Net Cash/Debt

PBYI$37M

PROK$75M

Current Ratio (TTM)

PBYI2.91x

PROK8.36x

Quick Ratio (TTM)

PBYI2.57x

PROK8.07x

Debt/Equity (TTM)

PBYI0.17x

PROK5.40x

Debt/Assets (TTM)

PBYI0.0%

PROK0.0%

Interest Coverage (TTM)

PBYIN/A

PROKN/A

Net Debt/EBITDA (TTM)

PBYI0.00x

PROK0.00x

Beta

PBYI1.36

PROK1.95

52W Performance

PBYI96.7%

PROK-46.6%

YTD Performance

PBYI78.3%

PROK-22.0%

% from 52W High

PBYI-0.8%

PROK-50.0%

% from 52W Low

PBYI124.7%

PROK33.8%

Asset Turnover (TTM)

PBYI1.15x

PROK0.00x

FCF Yield (TTM)

PBYI7.8%

PROK-30.4%

Earnings Yield (TTM)

PBYI5.1%

PROK-16.0%

Dividend Yield (TTM)

PBYIN/A

PROKN/A

Rule of 40

PBYI14.9

PROK-19,472.2

EV/GP/RG

PBYIN/A

PROKN/A

Ticker research

View PBYI research View PROK research

Metric	PBYI Puma Biotechnology Inc	PROK Prokidney Corp
Market & Valuation
Market Cap	$524M	$526M
Enterprise Value	$487M	$451M
Price	$10.29	$1.74
P/E Ratio	20.26x	N/A
P/S Ratio	2.26x	642.52x
EV/Sales	2.11x	551.08x
EV/EBITDA	10.51x	0.00x
P/B Ratio	3.54x	78.79x
P/FCF Ratio	12.75x	N/A
EV/FCF	11.86x	-2.82x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	788.85x
Revenue & Growth
Revenue (TTM)	$231M	$818K
Revenue Growth (YoY)	-2.9%	55.2%
Forward Rev Growth	-1.4%	-44.4%
Profitability
Gross Margin (TTM)	74.8%	0.0%
Operating Margin (TTM)	13.2%	0.0%
EBITDA Margin (TTM)	17.7%	-20827.6%
Net Margin (TTM)	11.6%	-10288.4%
FCF Margin (TTM)	17.8%	-19527.4%
Net Income (TTM)	$27M	$-84M
FCF (TTM)	$41M	$-160M
EPS (TTM)	$0.51	-$0.45
ROE (TTM)	20.8%	-2810.2%
ROA (TTM)	13.3%	-2739.0%
ROIC (TTM)	18.4%	0.0%
Financial Health
Cash	$37M	$75M
Debt	$0	$67K
Net Cash/Debt	$37M	$75M
Current Ratio (TTM)	2.91x	8.36x
Quick Ratio (TTM)	2.57x	8.07x
Debt/Equity (TTM)	0.17x	5.40x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.36	1.95
52W Performance	96.7%	-46.6%
YTD Performance	78.3%	-22.0%
% from 52W High	-0.8%	-50.0%
% from 52W Low	124.7%	33.8%
Efficiency & Yields
Asset Turnover (TTM)	1.15x	0.00x
FCF Yield (TTM)	7.8%	-30.4%
Earnings Yield (TTM)	5.1%	-16.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	14.9	-19,472.2
EV/GP/RG	N/A	N/A
Ticker research	View PBYI research	View PROK research

Valuation

P/E Ratio

PBYI

20.26x

P/S Ratio

PBYI

2.26x

PROK

642.52x

EV/FCF

PROK

-2.82x

PBYI

11.86x

Growth & revenue

Revenue Growth TTM

PROK

55.2%

PBYI

-2.9%

Forward Revenue Growth

PBYI

-1.4%

PROK

-44.4%

Profitability & performance

Gross Margin

PBYI

74.8%

PROK

0.0%

ROE

PBYI

20.8%

PROK

-2810.2%

FCF Yield %

PBYI

7.8%

PROK

-30.4%

52-Week Performance

PBYI

96.7%

PROK

-46.6%

Detailed metrics comparison

PBYI

Puma Biotechnology Inc

PROK

Prokidney Corp

Market Cap

PBYI$524M

PROK$526M

Enterprise Value

PBYI$487M

PROK$451M

Price

PBYI$10.29

PROK$1.74

P/E Ratio

PBYI20.26x

PROKN/A

P/S Ratio

PBYI2.26x

PROK642.52x

EV/Sales

PBYI2.11x

PROK551.08x

EV/EBITDA

PBYI10.51x

PROK0.00x

P/B Ratio

PBYI3.54x

PROK78.79x

P/FCF Ratio

PBYI12.75x

PROKN/A

EV/FCF

PBYI11.86x

PROK-2.82x

PEG Ratio

PBYIN/A

PROKN/A

Forward P/E (NTM)

PBYIN/A

PROKN/A

Forward P/S (NTM)

PBYIN/A

PROK788.85x

Revenue (TTM)

PBYI$231M

PROK$818K

Revenue Growth (YoY)

PBYI-2.9%

PROK55.2%

Forward Rev Growth

PBYI-1.4%

PROK-44.4%

Gross Margin (TTM)

PBYI74.8%

PROK0.0%

Operating Margin (TTM)

PBYI13.2%

PROK0.0%

EBITDA Margin (TTM)

PBYI17.7%

PROK-20827.6%

Net Margin (TTM)

PBYI11.6%

PROK-10288.4%

FCF Margin (TTM)

PBYI17.8%

PROK-19527.4%

Net Income (TTM)

PBYI$27M

PROK$-84M

FCF (TTM)

PBYI$41M

PROK$-160M

EPS (TTM)

PBYI$0.51

PROK-$0.45

ROE (TTM)

PBYI20.8%

PROK-2810.2%

ROA (TTM)

PBYI13.3%

PROK-2739.0%

ROIC (TTM)

PBYI18.4%

PROK0.0%

Cash

PBYI$37M

PROK$75M

Debt

PBYI$0

PROK$67K

Net Cash/Debt

PBYI$37M

PROK$75M

Current Ratio (TTM)

PBYI2.91x

PROK8.36x

Quick Ratio (TTM)

PBYI2.57x

PROK8.07x

Debt/Equity (TTM)

PBYI0.17x

PROK5.40x

Debt/Assets (TTM)

PBYI0.0%

PROK0.0%

Interest Coverage (TTM)

PBYIN/A

PROKN/A

Net Debt/EBITDA (TTM)

PBYI0.00x

PROK0.00x

Beta

PBYI1.36

PROK1.95

52W Performance

PBYI96.7%

PROK-46.6%

YTD Performance

PBYI78.3%

PROK-22.0%

% from 52W High

PBYI-0.8%

PROK-50.0%

% from 52W Low

PBYI124.7%

PROK33.8%

Asset Turnover (TTM)

PBYI1.15x

PROK0.00x

FCF Yield (TTM)

PBYI7.8%

PROK-30.4%

Earnings Yield (TTM)

PBYI5.1%

PROK-16.0%

Dividend Yield (TTM)

PBYIN/A

PROKN/A

Rule of 40

PBYI14.9

PROK-19,472.2

EV/GP/RG

PBYIN/A

PROKN/A

Ticker research

View PBYI research View PROK research

Metric	PBYI Puma Biotechnology Inc	PROK Prokidney Corp
Market & Valuation
Market Cap	$524M	$526M
Enterprise Value	$487M	$451M
Price	$10.29	$1.74
P/E Ratio	20.26x	N/A
P/S Ratio	2.26x	642.52x
EV/Sales	2.11x	551.08x
EV/EBITDA	10.51x	0.00x
P/B Ratio	3.54x	78.79x
P/FCF Ratio	12.75x	N/A
EV/FCF	11.86x	-2.82x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	788.85x
Revenue & Growth
Revenue (TTM)	$231M	$818K
Revenue Growth (YoY)	-2.9%	55.2%
Forward Rev Growth	-1.4%	-44.4%
Profitability
Gross Margin (TTM)	74.8%	0.0%
Operating Margin (TTM)	13.2%	0.0%
EBITDA Margin (TTM)	17.7%	-20827.6%
Net Margin (TTM)	11.6%	-10288.4%
FCF Margin (TTM)	17.8%	-19527.4%
Net Income (TTM)	$27M	$-84M
FCF (TTM)	$41M	$-160M
EPS (TTM)	$0.51	-$0.45
ROE (TTM)	20.8%	-2810.2%
ROA (TTM)	13.3%	-2739.0%
ROIC (TTM)	18.4%	0.0%
Financial Health
Cash	$37M	$75M
Debt	$0	$67K
Net Cash/Debt	$37M	$75M
Current Ratio (TTM)	2.91x	8.36x
Quick Ratio (TTM)	2.57x	8.07x
Debt/Equity (TTM)	0.17x	5.40x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.36	1.95
52W Performance	96.7%	-46.6%
YTD Performance	78.3%	-22.0%
% from 52W High	-0.8%	-50.0%
% from 52W Low	124.7%	33.8%
Efficiency & Yields
Asset Turnover (TTM)	1.15x	0.00x
FCF Yield (TTM)	7.8%	-30.4%
Earnings Yield (TTM)	5.1%	-16.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	14.9	-19,472.2
EV/GP/RG	N/A	N/A
Ticker research	View PBYI research	View PROK research